Login / Signup
Javier Gonzalez
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Dna Damage
Cross Sectional
High Grade
Placebo Controlled
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Kristina A Fanucci
,
Mary Jo Pilat
,
Derek Shyr
,
Yu Shyr
,
Scott A Boerner
,
Jing Li
,
Diane E Durecki
,
Jan Drappatz
,
Vinay K Puduvalli
,
Frank Scott Lieberman
,
Javier Gonzalez
,
Pierre Giglio
,
Susan Percy Ivy
,
Ranjit S Bindra
,
Antonio Omuro
,
Patricia M LoRusso
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma.
Cancer research communications
3 (2) (2023)
Kristina A Fanucci
,
Mary Jo Pilat
,
Derek Shyr
,
Yu Shyr
,
Scott A Boerner
,
Jing Li
,
Diane E Durecki
,
Jan Drappatz
,
Vinay K Puduvalli
,
Frank Scott Lieberman
,
Javier Gonzalez
,
Pierre Giglio
,
Susan Percy Ivy
,
Ranjit S Bindra
,
Antonio Omuro
,
Patricia M LoRusso
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma.
Cancer research communications
3 (2) (2023)